Parkinson's disease (PD) is a multifactorial neurodegenerative disorder characterised by the preferential loss of dopaminergic neurons in the region of the brain known as the substantia nigra. Recent genome-wide association studies have identified 28 genetic risk variants for non-familial PD [1] . Mutations in the multi-domain leucine-rich repeat kinase 2 (LRRK2) and in PTEN-induced putative kinase 1 (PINK1) are prominent causes of autosomal dominant and autosomal recessive PD, respectively. A central task to understanding the aetiology of PD is to connect these genes to common cellular pathways. Several lines of evidence have linked LRRK2 to the endolysosomal pathway and to mitochondrial dynamics, whilst PINK1 is firmly established as a key regulator of mitophagy, the selective autophagic degradation of mitochondria [2] [3] [4] [5] . New work now reveals that these kinases share an ability to regulate the activity of multiple members of the small GTPase family of Rab proteins through phosphorylation [6, 7] .
Steger et al. [7] took an unbiased global phospho-proteomics approach to identify physiological substrates of LRRK2. As a first screen, they quantified changes in the phosphoproteome of knock-in fibroblasts harbouring an activating mutation in LRRK2 (G2019S), following treatment with two structurally divergent LRRK2 inhibitors. In a second experimental configuration aimed at eliminating off-target effects, they utilised a knock-in variant of LRRK2 that had been engineered to be insensitive to a newly developed LRRK2 inhibitor. Specific LRRK2 substrates could then be identified by comparing drug-dependent changes in the phosphoproteome with that of isogenic wild-type cells. From over 9,000 quantified phosphopeptides, they identified 47 that were sensitive to both inhibitors used in the first screen. In the orthogonal screen 128 sites were exclusively sensitive to drug application in wild-type cells. How many sites overlap between the screens? In fact, only two: the autophosphorylation site pSer935 in LRRK2 and pThr73 of the small GTPase Rab10. In follow-up studies, a selection of Rabs (Rab3, Rab8 and Rab10) bearing this conserved threonine were shown to be LRRK2 substrates in vitro and in cell models.
In the other recent study, Lai et al. [6] set out to identify PINK1-dependent substrates from phosphoproteomic analyses. PINK1 has a short-half life and is rapidly degraded following its constitutive import into mitochondria. However, when mitochondria become depolarised, PINK1 accumulates on the surface of the mitochondria, where it phosphorylates both ubiquitin and Parkin at Ser65, the combination of which leads to activation of Parkin's ubiquitin E3-ligase activity and consequently to mitophagy [5] . Interestingly, PINK1 knockout rats show progressive neurodegeneration, whilst Parkin knockouts are not affected, suggesting that there may be additional PINK1 substrates that are relevant to neuropathy [8] . Lai et al. [6] treated HEK293 cells expressing wild-type or kinase-inactive PINK1 with a chemical uncoupling agent to depolarize mitochondria and induce the accumulation of PINK1. Similarly to Steger et al. [7] , these authors quantified changes in the phosphoproteome, but in this study they used a mitochondrial-enriched fraction from the PINK1-expressing cells [6] . From more than 12,000 phosphosites, only 16 could be clearly shown to increase in a manner dependent on PINK1 activity: reassuringly, these included the previously identified pSer65-ubiquitin site and a PINK1 autophosphorylation site. Remarkably, the most responsive peptides in this group included equivalent pSer111 phosphopeptides from three closely related Rab GTPases -Rab8A, Rab8B and Rab13. Three lines of evidence suggest that these Rab proteins are not directly phosphorylated by PINK1: a structural comparison of the Rabs with established direct PINK1 substrates (ubiquitin and Parkin) revealed no similarities at the phosphorylation sites; PINK1 failed to phosphorylate these Rabs in in vitro kinase reactions; and the Rabs showed a delay in phosphorylation following depolarisation compared with ubiquitin and Parkin. Thus, it seems likely that PINK1 activates a further kinase to effect Rab phosphorylation.
It is striking that both kinases implicated in PD converge on Rab family GTPases, which are largely regarded as regulators of membrane trafficking events, each Rab governing activities at a different organelle (Figure 1 ) [9] . Rabs themselves are geranylgeranylated and cycle both between GTP-and GDP-bound states (active and inactive, respectively) as well as between the plasma membrane and the cytosol with the assistance of a chaperone known as a guanine nucleotide dissociation inhibitor (GDI). Steger et al. [7] looked for proteins that differentially bound to a nonphosphorylatable T72A form of Rab8 compared with a phosphomimetic T72E form and identified GDIs 1 and 2, components of the geranylgeranyl transferase complex, the Rab8a guanine nucleotide exchange factor (GEF) Rabin8, and a guanine nucleotide Further experiments that are consistent with structural models confirmed that threonine phosphorylation of Rab8 abrogates Rabin8-dependent nucleotide exchange and binding to GDI [7] . Lai et al. [6] made corresponding mutations in the PINK1-dependent phosphosite of Rab8 (S111A and S111E) and also showed that a failure of Rabin8-mediated nucleotide exchange was associated with Rab8 phosphorylation. These studies suggest that these two distinct PD-associated kinases serve to slow the reloading of selected Rabs into their active state, some of which (such as Rab8) are common to both kinases.
Collectively, Rabs are central players in the cellular membrane economy, helping to direct the flux of vesicular traffic and establish compartmental identities. Several lines of evidence link them to PD. Most directly, loss of Rab39B causes early-onset PD and Rab29 (also known as Rab7L) lies within the PARK16 nonfamilial risk locus [1, 10] . Lewy bodies, the histological hallmark of PD, contain high levels of a-synuclein. Overexpression of several Rabs (Rab1, Rab3A, and Rab8A) can relieve the toxic effects of high levels of a-synuclein in neuronal cell models of PD [11] . LRRK2 has previously been shown to interact with Rab5B, Rab32, Rab38 and Rab29, but it is unclear if any of these Rabs would be a preferred substrate [12] [13] [14] .
One hallmark of PD appears to be defective sorting to the lysosome or impaired function of these organelles. Several PD-related genes map to this pathway, including VPS35, a component of the retromer complex Dispatches not only lead to the most common lysosomal storage disorder, Gaucher disease, but also increase the risk of PD by 20-30-fold. Expression of activating LRRK2 mutants suppresses the Rab7-dependent maturation of endosomes and influences Rab7 membrane cycling and activation status [4] , whilst Rab29 expression rescues several LRRK2-associated defects, including the retromer-dependent sorting of the lysosomal cargo receptor cationic-independent mannose 6-phosphate receptor [3] . However, there is no current indication that Rab7 or Rab29 might be direct substrates of LRRK2.
Could these findings also relate to mitophagy and the pathway to which PINK1 has hitherto been most strongly linked? What is the role of Rab proteins in this process? As all autophagosomes ultimately fuse with lysosomes, there is an inextricable link between mitophagy and lysosomal function. While multiple Rabs have been linked to autophagy [15] , Rab proteins have been suggested to play more specialised roles that are specific to mitophagy. The Rab GAP TBC1D15 identified by Steger et al. [7] as a phospho-sensitive Rab8A-interacting protein is required for co-ordinating the wrapping of the expanding autophagosomal membrane around the mitochondrial body. This process has been linked to Rab7 function, since Rab7 depletion corrects misdirected autophagosomal expansion in TBC1D15 -/-cells [16] . Rab8B has a key role in the autophagic clearance of bacteria and binds to TANK-binding kinase 1 (TBK-1) [17] . This kinase plays a critical role in mitophagy, including binding to and phosphorylation of the adaptor proteins optineurin and NDP52, which link the damaged mitochondrion to the autophagosomal membrane [18, 19] . Recently, a novel pathway of vesicle transport from mitochondria to lysosomes has been discovered that depends on PINK1, Parkin and VPS35 [20] . These vesicles are proposed to remove oxidised proteins from mitochondria without a requirement for full mitophagy. A role for as yet unidentified Rab proteins is implied by the principle of conservation of mechanism in intracellular membrane fusion.
The focus on Rabs downstream of distinct PD-associated kinases, coming from large-scale phosphoproteomic studies of unparalleled stringency, most likely brings us closer to a unified view of PD. An unanswered question is whether there is a pre-eminent Rab protein whose loss of function is critical to PD, or if PD represents a consequence of a general slow-down in Rab-mediated membrane trafficking. Moreover, this new work highlights an emerging theme of Rab protein regulation through phosphorylation.
